Download The University of Texas M - MD Anderson Cancer Center

The University of Texas M. D. Anderson Cancer Center
Integrative Medicine Program
Simms Mann Lecture Series
Upcoming
“Biobehavioral Mechanisms and Tumor
Progression in Ovarian Cancer”
Susan K. Lutgendorf, PhD
Professor, Departments of Psychology,
Obstetrics and Gynecology, and Urology
Member of Holden Comprehensive Cancer Center
Fellow of the Academy of Behavioral Science
University of Iowa
Iowa City, IA
Thursday, February 18, 2010
12:00 noon – 1:00 p.m.
Hickey Auditorium R11.1400
The University of Texas M. D. Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Texas M. D. Anderson Cancer Center designates this educational activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Audience:
All Employees, Managers, Physicians, Scientists, Nurses, Students, Volunteers, Patients, Community, Other Healthcare Professionals
Educational Objectives:
After attending this presentation, participants should be able to:
Identify major CAM approaches used by cancer patients and why they use them
Discuss the CAM approaches that may be harmful alone or in combination with conventional cancer treatments, those not known to be harmful and felt to be beneficial to patients
Discuss CAM approaches shown by appropriate research methods to be beneficial for quality of life or other clinical outcomes when integrated with conventional cancer treatment
Apply increased knowledge and confidence in discussing with and guiding patients who choose to use CAM alone or in combination with their conventional cancer treatments
Identify CAM treatments to promote wellness, to manage symptoms or to treat cancer
The University of Texas M. D. Anderson Cancer Center's Faculty Disclosure Policy
It is the policy of The University of Texas M. D. Anderson Cancer Center that the planning committee members and all faculty/presenters must disclose any relevant financial relationships with commercial
interests whose products may be discussed in the activities, if any. M. D. Anderson also requires that faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of
pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.